Founded in 1952 by visionary physicians determined to find better treatments for their patients, The Lundquist Institute continues to be defined by its unique “bedside to bench to bedside” approach, translating clinical challenges into scientific inquiry, and scientific discoveries back into patient care.
Today, over 150 principal investigators and 400 research staff are driving forward more than 600 active studies and 100+ clinical trials, delivering solutions that are transforming lives. Affiliated with the David Geffen School of Medicine at UCLA and partnered with Harbor-UCLA Medical Center, The Lundquist Institute leads advancements in areas ranging from cancer biology and infectious diseases, and respiratory medicine to translational genomics.
Introducing The Lundquist Institute’s Research Innovation Hubs
Our Innovation Hubs represent a bold step forward in aligning scientific excellence with real-world impact.
Over the coming weeks, we will be unveiling detailed profiles of each Hub, including focus areas, scientific leadership, and opportunities for partnership. We invite you to check back as we share more.
Advanced Therapeutics &
Biomedical Technologies
Restoring health and quality of life through technology innovation
Infectious Diseases &
Immunology
Meeting the growing challenge of infections, cancer, and immunologic diseases
Translational Science &
Population Health
Applying scientific advances to close gaps in personal and community health
Systems Medicine &
Precision Prevention
Averting chronic disease via prevention, early detection, and novel interventions